CLINICAL RESEARCH
Does treatment with sub-lingual allergen-specific immunotherapy reduce adenoid size and improve quality of life among Egyptian children?
1
Microbiology and Immunology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
2
Department of Otolaryngology, Port Fouad Hospital, Port Fouad, Egypt
3
Otolaryngology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
Submission date: 2019-02-01
Final revision date: 2019-05-05
Acceptance date: 2019-05-05
Publication date: 2019-07-18
Arch Med Sci Civil Dis 2019;4(1):51-57
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Adenoidal hypertrophy is a paediatric problem. Adenoidectomy contributes to post-operative complications. Allergic rhinitis is a major health problem. Its prevalence in Egypt and the Middle East is up to 9%. The aim of the present study was to evaluate the effect of sub-lingual immunotherapy on adenoid size and/or quality of life among children suffering from adenoid hypertrophy with allergic rhinitis in Suez Canal University Hospital.
Material and methods:
Forty-six children suffering from adenoid hypertrophy and allergic rhinitis were recruited for this purpose. Skin prick test was administered to identify the causative allergen. All patients received sub-lingual immunotherapy. Lateral X-ray, serum total immunoglobulin E, symptoms, and sign score were recorded for all patients before and after the treatment.
Results:
The nasal symptoms and adenoidal size of the examined patients were significantly decreased after immunotherapy was applied, and thus there was an improvement in the quality of life among those patients.
Conclusions:
It was concluded that sub-lingual immunotherapy was an alternative treatment of adenoidectomy in children with moderate adenoid hypertrophy with allergic rhinitis. Surgical treatment for children who suffer from severe adenoid hypertrophy with allergic rhinitis could not be considered as obligatory because medical treatment has no effect on the size of adenoids nor on quality of life.
Adenoidal hypertrophy is a paediatric problem. Adenoidectomy contributes to post-operative complications. Allergic rhinitis is a major health problem. Its prevalence in Egypt and the Middle East is up to 9%. The aim of the present study was to evaluate the effect of sub-lingual immunotherapy on adenoid size and/or quality of life among children suffering from adenoid hypertrophy with allergic rhinitis in Suez Canal University Hospital.
Material and methods:
Forty-six children suffering from adenoid hypertrophy and allergic rhinitis were recruited for this purpose. Skin prick test was administered to identify the causative allergen. All patients received sub-lingual immunotherapy. Lateral X-ray, serum total immunoglobulin E, symptoms, and sign score were recorded for all patients before and after the treatment.
Results:
The nasal symptoms and adenoidal size of the examined patients were significantly decreased after immunotherapy was applied, and thus there was an improvement in the quality of life among those patients.
Conclusions:
It was concluded that sub-lingual immunotherapy was an alternative treatment of adenoidectomy in children with moderate adenoid hypertrophy with allergic rhinitis. Surgical treatment for children who suffer from severe adenoid hypertrophy with allergic rhinitis could not be considered as obligatory because medical treatment has no effect on the size of adenoids nor on quality of life.
REFERENCES (28)
1.
Kenna M, Amin A. Anatomy and physiology of the oral cavity. In: Ballenger’s Otorhinolaryngology Head and Neck Surgery. Mc-Graw Hill 2009; 769-74.
2.
Hellings P, Fokkens W. Allergic rhinitis and its impact on otorhinolaryngology. J Allergy 2006; 61: 656-64.
3.
Stuck B, Gotte K, Windfuhr J, Genzwürker H, Schroten H, Tenenbaum T. Tonsillectomy in children. J Dtsch Arztebl Int 2008; 105: 852-60.
4.
Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (5 Suppl): S147-334.
5.
Wilson K, Spector M, Orlandi R. Types of rhinitis. J Otolaryngol Clin North Am 2011; 44: 549-59.
6.
Natt R, Karkos P, Natt D, Theochari E, Karkanevatos A. Treatment trends in allergic rhinitis and asthma: a British ENT survey. BMC Ear Nose Throat Disord 2011; 11: 11-3.
7.
Abdulrahman H, Hadi U, Tarraf H, et al. Nasal allergies in the Middle Eastern population: results from the “Allergies in Middle East Survey”. J Am J Rhinol Allergy 2012; 26: 3-23.
8.
Moingeon P, Mascarell L. Induction of tolerance via the sublingual route: mechanisms and applications. J Clin Dev Immunol 2012; 2012: 623474.
9.
Moingeon P. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician. J Allergy Clin Immunol Pract 2013; 1: 228-41.
10.
Spector S, Nicklas R, Chapman J, et al. Symptom severity assessment of allergic rhinitis: part 1. J Ann Allergy Asthma Immunol 2003; 91: 105-14.
11.
Orji F, Ezeanolue B. Evaluation of adenoidal obstruction in children: clinical symptoms compared with roentgenographic assessment. J Laryngol Otol 2008; 122: 1201-5.
12.
Egeli E, Oghan F, Ozturk O, Harputluoglu U, Yazici B. Measuring the correlation between adenoidal-nasopharyngeal ratio (AN ratio) and tympanogram in children. J Pediatr Otorhinolaryngol 2005; 69: 229-33.
13.
Winther B, Innes D. The human adenoid – a morphologic study. J Arch Otolaryngol Head Neck Surg 1994; 120: 144-9.
14.
Wysocka J, Hassmann E, Lipska A, Musiatowicz M. Naive and memory T cells in hypertrophied adenoids in children according to age. J Int J Pediatr Otorhinolaryngol 2003; 67: 237-41.
15.
Somayaj G, Rajeshwari A, Jain M. Significance of adenoid nasopharyngeal ratio in the assessment of adenoid hypertrophy in children. J Res Otolaryngol 2004; 1: 1-5.
16.
Evcimik M, Dogru M, Ciri A, Nepesov M. Adenoid hypertrophy in children with allergic disease and influential factors. J Int J Pediatr Otorhinolaryngol 2015; 79: 694-7.
17.
Kenawy M, Awad A, El-Shafei A, Helmi N, Abdel-Hamid Y, El-Zohery Y. House dust mites associated with the asthmatic patientsin some houses of Cairo, A.R. Egypt. J Egypt Acad J Biolog Sci 2012; 4: 1-5.
18.
Mailhol C, Didier A. Allergen-specific immunotherapy in the treatment of pollen allergy. J Rev Mal Respir 2013; 30: 142-51.
19.
Niederberger V. Allergen-specific immunotherapy. J Immunol Lett 2009; 122: 131-3.
20.
Chang H, Han D, Mo J. Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites. J Clin Exp Otorhinolaryngol 2009; 2: 136-40.
21.
Rolinck-Werninghaus C, Wolf H, Liebke C, et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. J Allergy 2004; 59: 1285-93.
22.
Cengel S, Akyol M. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. J Pediatr Otorhinolaryngol 2006; 70: 639-45.
23.
Gozal L, Gozal D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. J Pediatrics 2008; 122: 149-55.
24.
Jung Y, Kim H, Min J, Dhong H, Chung S. Role of intranasal topical steroid in pediatric sleep disordered breathing and influence of allergy, sinusitis, and obesity on treatment outcome. J Clin Exp Otorhinolaryngol 2011; 4: 27-32.
25.
Chadha N, Zhang L, Mendoza-Sassi R, César J. Using nasal steroids to treat nasal obstruction caused by adenoid hypertrophy: does it work? J Otolaryngol Head Neck Surg 2009; 140: 139-47.
26.
Lepcha A, Kurien M, Job A, Jeyaseelan L, Thomasc K. Chronic adenoid hypertrophy in children – is steroid nasal spray beneficial? J Indian J Otolaryngol Head Neck Surg 2002; 54: 280-4.
27.
Modrzyński M, Rapiejko P. The incidence of adenoid hypertrophy in allergic diseases. J Case Rep Clin Pract Rev 2004; 5: 487-91.
28.
Modrzynski M, Zawisza E. An analysis of the incidence of adenoid hypertrophy in allergic children. J Int J Pediatr Otolaringol 2007; 71: 713-9.
Share
RELATED ARTICLE
| ISSN: | 2451-0637 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
